U.S. IT Stock News

If you are wondering whether StubHub Holdings at around US$6.82 reflects its true potential or is still mispriced, this article will help you frame that question using numerical analysis rather than hype. The shares have moved 10.5% over the last week, after a 4.5% decline over the past month and a 52.3% decline year to date. This naturally raises questions about both risk and the possibility of recovery. Recent coverage around StubHub Holdings has focused on its position in the ticketing...

Ryder System (NYSE:R) has again been named to Fortune's "America's Most Innovative Companies" list, recognizing its focus on technology and digital tools in logistics. The company has opened a new commercial truck facility in Alabama, expanding its presence in the Southeast and adding capacity to its logistics and transportation network. Ryder System sits at the center of freight, fleet, and supply chain services, an area where reliability and efficiency matter as much as price. The Fortune...

Alkami Technology, NasdaqGS:ALKT, has launched what it calls the industry's first unified Digital Sales & Service Platform for financial institutions. The company also introduced Alkami Engage, a behavioral analytics and digital adoption tool aimed at supporting more personalized digital banking experiences. These back to back product launches expand Alkami's digital banking infrastructure offering for banks and credit unions of various sizes. Alkami Technology enters this product rollout...

Perma-Pipe International Holdings (PPIH) has reported another busy quarter, with Q3 2026 revenue of about US$61.1 million and basic EPS of US$0.78, alongside trailing 12 month revenue of roughly US$200.8 million and EPS of US$1.73 that frame the latest numbers in a wider context. Over recent periods the company has seen quarterly revenue move from US$44.99 million in Q4 2025 to US$46.75 million in Q1 2026, US$47.90 million in Q2 2026 and US$61.15 million in Q3 2026. Basic EPS tracked from...

Align Technology was named a Top 100 Global Innovator in the latest LexisNexis Innovation Momentum report. This is the fifth consecutive year the company has received this recognition. The ranking highlights Align Technology's emphasis on R&D and the strength of its global patent portfolio. Align Technology, listed on NasdaqGS:ALGN, sits at a share price of $185.02, with the stock up 6.0% over the past week and 5.1% over the past month. Returns of 18.6% year to date and 7.9% over the past...

Signet Jewelers (NYSE:SIG) reported its largest ever single-year fundraising total for St. Jude Children's Research Hospital. The company highlighted this record figure as a milestone in its long-running partnership with the hospital. The announcement underscores Signet's focus on social responsibility alongside its core jewelry retail operations. As the largest specialty jewelry retailer in the U.S., Signet operates brands many consumers recognize from malls and online shopping. The...

Wondering if V2X at around US$68.83 is offering value or asking you to pay up? This article breaks down what the current price really implies. The stock has seen mixed short term moves, with a 2.5% decline over the last 7 days, a 2.5% gain over the last 30 days, and returns of 23.9% year to date and 42.0% over the past year. Recent attention on V2X has focused on its role within the Aerospace & Defense sector and how its contract profile and government exposure fit into broader investor...

We'd be surprised if Porch Group, Inc. ( NASDAQ:PRCH ) shareholders haven't noticed that the Chief Operating Officer...

If you are wondering whether Ocular Therapeutix at around US$8.91 is priced attractively or already reflecting a lot of optimism, starting with a clear look at value can help you frame that question. The stock has seen a mix of moves, with a 5.8% gain over the last 7 days, a 3.2% return over the past month, a 24.3% gain over 1 year, set against a 24.6% decline year to date and a 41.7% decline over 5 years. Over the past year, headlines have focused on Ocular Therapeutix as a specialist in...

The United States market has shown robust performance, rising 3.4% over the last week and 35% over the past year, with earnings projected to grow by 16% annually. In such a thriving market, identifying stocks with strong potential for growth often involves looking beyond well-known names to those that might not be on every investor's radar. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that could offer surprising value and stability...

NioCorp Developments (NasdaqGM:NB) recently announced a non binding term sheet with Traxys North America LLC that outlines an extensive marketing and offtake framework for critical minerals from its Elk Creek Project. See our latest analysis for NioCorp Developments. The Traxys term sheet arrives after a sharp shift in sentiment, with the share price up 18.44% in the last day and a 1 year total shareholder return of 55.94% despite a weaker 90 day share price return. Recent momentum appears to...

The United States market has experienced a notable upswing, rising 3.4% over the last week and climbing 35% in the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering hidden opportunities that align with these positive trends.

Wondering whether Praxis Precision Medicines at US$339.93 is priced for its future potential or already reflecting high expectations? This article breaks down what the current share price could mean for you. The stock has recent returns of 6.2% over 7 days, 11.5% over 30 days and 18.7% year to date, with a very large 1 year return that is more than 10x. Recent coverage of Praxis Precision Medicines has focused on its position in the biotech space and how sentiment around its pipeline and...

ANI Pharmaceuticals (NasdaqGM:ANIP) has launched Carbamazepine Extended-Release Capsules, a limited competition generic version of Carbatrol. The company also reported publication of Phase 4 clinical trial results for ILUVIEN in a leading ophthalmology journal. These updates expand ANI's presence in specialty generics and reinforce its role in high-value therapeutic areas. ANI Pharmaceuticals enters this news cycle with its shares at $76.48 and a 1 year return of 10.5%. Over the past 3...

Over the last 7 days, the United States market has risen by 3.4%, contributing to a remarkable 35% increase over the past year, with earnings forecasted to grow by 16% annually. In this buoyant environment, identifying stocks that are potentially undervalued yet exhibit insider action can be an intriguing strategy for investors seeking opportunities within the small-cap segment.

The United States market has shown robust growth, rising 3.4% over the last week and climbing 35% in the past year, with earnings projected to increase by 16% annually. In such a thriving environment, identifying undervalued stocks can present opportunities for investors seeking to capitalize on potential gains while navigating current market conditions.

Somnigroup International has agreed to acquire Leggett & Platt in an all stock transaction valued at $2.5 billion. Leggett & Platt shareholders are set to receive Somnigroup stock, with Leggett & Platt continuing as a standalone business unit. The deal has unanimous board approval and is targeted to close by year end 2026, subject to shareholder and regulatory approvals. For investors watching NYSE:LEG, this deal comes as the stock trades around $11.35 after a mixed longer term record. The...

Over the last 7 days, the United States market has risen 3.4%, and over the past year, it's up by an impressive 35%, with earnings forecasted to grow by 16% annually. For investors willing to explore beyond well-known companies, penny stocks—often representing smaller or newer enterprises—can offer intriguing opportunities. Despite their vintage label, these stocks can present underappreciated growth potential at lower price points when backed by strong balance sheets and solid fundamentals.

The United States market has shown robust performance recently, climbing 3.4% in the last week and surging 35% over the past year, with earnings projected to grow by 16% annually in the coming years. In such a dynamic environment, identifying small-cap stocks with strong fundamentals and growth potential can be key to uncovering promising investment opportunities.

The United States market has shown impressive growth, rising 3.4% in the last week and 35% over the past year, with earnings projected to grow by 16% annually in the coming years. In this thriving environment, dividend stocks like Paychex stand out as they offer both potential income through dividends and stability amidst market fluctuations.

This article walks through the key signals behind Pilgrim's Pride at around US$33.64 so you can consider whether it is starting to look like value or still has risk priced in. The share price has seen pressure recently, with returns of 6.4% over 7 days, 8.4% over 30 days and 15.6% year to date. It is still sitting on gains of 73.7% over 3 years and 60.3% over 5 years, while the past 12 months show a 34.0% decline. Recent coverage has focused on how investors are reassessing poultry...

Silence Therapeutics plc ( NASDAQ:SLN ) insiders who purchased shares in the last 12 months were richly rewarded last...

We wouldn't blame MoonLake Immunotherapeutics ( NASDAQ:MLTX ) shareholders if they were a little worried about the fact...

Mama's Creations (MAMA) just closed FY 2026 with fourth quarter revenue of US$54.0 million and EPS of US$0.05, capping a year where trailing 12 month revenue reached US$171.7 million and EPS came in at US$0.14. The company has seen quarterly revenue move from US$33.6 million in Q4 FY 2025 to US$54.0 million in Q4 FY 2026, alongside EPS shifting from US$0.04 to US$0.05 over the same period. This is setting up a results season in which investors are closely watching how efficiently that revenue...